Your browser doesn't support javascript.
loading
Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes.
Garg, Manik; Couturier, Dominique-Laurent; Nsengimana, Jérémie; Fonseca, Nuno A; Wongchenko, Matthew; Yan, Yibing; Lauss, Martin; Jönsson, Göran B; Newton-Bishop, Julia; Parkinson, Christine; Middleton, Mark R; Bishop, D Timothy; McDonald, Sarah; Stefanos, Nikki; Tadross, John; Vergara, Ismael A; Lo, Serigne; Newell, Felicity; Wilmott, James S; Thompson, John F; Long, Georgina V; Scolyer, Richard A; Corrie, Pippa; Adams, David J; Brazma, Alvis; Rabbie, Roy.
Afiliación
  • Garg M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridgeshire, UK.
  • Couturier DL; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, UK.
  • Nsengimana J; University of Leeds School of Medicine, Leeds, United Kingdom.
  • Fonseca NA; Biostatistics Research Group, Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Wongchenko M; CIBIO/InBIO-Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, Rua Padre Armando Quintas, 4485-601, Vairão, Portugal.
  • Yan Y; Oncology Biomarker Development, Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Lauss M; Oncology Biomarker Development, Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Jönsson GB; Lund University Cancer Center, Lund University, Lund, Sweden.
  • Newton-Bishop J; Lund University Cancer Center, Lund University, Lund, Sweden.
  • Parkinson C; University of Leeds School of Medicine, Leeds, United Kingdom.
  • Middleton MR; Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Bishop DT; Oxford NIHR Biomedical Research Centre and Department of Oncology, University of Oxford, Oxford, UK.
  • McDonald S; University of Leeds School of Medicine, Leeds, United Kingdom.
  • Stefanos N; Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Tadross J; Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Vergara IA; Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Lo S; Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia.
  • Newell F; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Wilmott JS; Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia.
  • Thompson JF; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Long GV; Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Scolyer RA; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Corrie P; Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia.
  • Adams DJ; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Brazma A; Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia.
  • Rabbie R; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Nat Commun ; 13(1): 2841, 2022 May 17.
Article en En | MEDLINE | ID: mdl-35581257
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article